Medicamen Biotech informs about disclosure

30 Dec 2020 Evaluate
Medicamen Biotech has informed that it has enclosed the disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, received from Shivalik Rasayan & Growel Remedies for purchase and sale of equity shares.

The above information is a part of company’s filings submitted to BSE.

Medicamen Biotech Share Price

304.70 -0.15 (-0.05%)
25-Feb-2026 10:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1757.80
Dr. Reddys Lab 1295.60
Cipla 1337.50
Zydus Lifesciences 908.10
Lupin 2263.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×